Nestle completes acquisition of L'Oreal 50% stake in Galderma Nestle (NSRGY) announced it has completed its acquisition of L'Oreal's (LRLCY) 50% stake in Galderma, as originally announced on February 11. Galderma will henceforth operate as the pharmaceutical arm of Nestle Skin Health S.A.
News For LRLCY;NSRGY From The Last 14 Days
Check below for free stories on LRLCY;NSRGY the last two weeks.
L'Oreal downgraded to Outperform from Strong Buy at Raymond James Raymond James downgraded L'Oreal to Outperform and removed the stock from its European Conviction List citing the CEO's cautious message on cosmetics market momentum in the second half of 2014.